End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
28,000 KRW | -0.18% | -.--% | +8.32% |
2023 | NeoPharm CO., LTD. Reports Earnings Results for the First Quarter Ended March 31, 2023 | CI |
2019 | NeoPharm CO., LTD. announced that it has received KRW 31.970667276 billion in funding | CI |
Sales 2024 * | 120B 86.64M | Sales 2025 * | 145B 105M | Capitalization | 219B 158M |
---|---|---|---|---|---|
Net income 2024 * | 23B 16.61M | Net income 2025 * | 30B 21.66M | EV / Sales 2024 * | 0.75 x |
Net cash position 2024 * | 128B 92.7M | Net cash position 2025 * | 152B 110M | EV / Sales 2025 * | 0.46 x |
P/E ratio 2024 * |
10
x | P/E ratio 2025 * |
7.63
x | Employees | 142 |
Yield 2024 * |
2.68% | Yield 2025 * |
2.68% | Free-Float | 56.96% |
1 day | -0.18% | ||
1 month | +7.69% | ||
3 months | +7.69% | ||
6 months | +19.66% | ||
Current year | +8.32% |
Managers | Title | Age | Since |
---|---|---|---|
Yang-Soo Kim
CEO | Chief Executive Officer | 54 | 12-07-31 |
Yoon Kim
CTO | Chief Tech/Sci/R&D Officer | 59 | 00-06-30 |
Woo-Jae Lim
BRD | Director/Board Member | 45 | 21-03-24 |
Members of the board | Title | Age | Since |
---|---|---|---|
Yoon Kim
CTO | Chief Tech/Sci/R&D Officer | 59 | 00-06-30 |
Dong-Jin Choi
BRD | Director/Board Member | 64 | 19-03-20 |
Yang-Soo Kim
CEO | Chief Executive Officer | 54 | 12-07-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-31 | 28,000 | -0.18% | 79,035 |
24-05-30 | 28,050 | -0.71% | 53,007 |
24-05-29 | 28,250 | -0.53% | 62,269 |
24-05-28 | 28,400 | +3.27% | 78,190 |
24-05-27 | 27,500 | -1.79% | 51,381 |
End-of-day quote Korea S.E., May 30, 2024
More quotesEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+8.32% | 158M | |
+0.32% | 262B | |
+18.76% | 20.37B | |
-.--% | 19.29B | |
+16.91% | 12.64B | |
-16.59% | 8.94B | |
+33.93% | 8.62B | |
+9.55% | 5.93B | |
-12.08% | 3.92B | |
-16.83% | 3.84B |
- Stock Market
- Equities
- A092730 Stock